Analyzing the Therapeutic Mechanism of Mongolian Medicine Zhonglun-5 in Rheumatoid Arthritis Using a Bagging Algorithm with Serum Metabonomics

Figure 6

Set diagram of heatmap and drug-biomarker network of potential biomarkers regulated by ZL. (PG1, prostaglandin G1; 10-HHP, 10-hydroperoxy-H4-neuroprostane; GA2, ganglioside GA2 (d18 : 1/18 : 0); GD3, ganglioside GD3 (d18 : 1/23 : 0); GM2, ganglioside GM2 (d18 : 0/18 : 1 (11Z)); PA, palmitoleic acid; ESA, eicosapentaenoic acid; α-LA, α-linolenic acid; SA, stearic acid; OTC, octadecanamide; ECA, eicosadienoic acid; PLG, phenylacetyl glycine; L-V, L-valine; MLC, myristoyl glycine; N-U, N-undecanoylglycine; L-P, L-proline; TDC, tauroursodeoxycholic acid; GTS, gytosine; CTP, 13′-carboxy-γ-tocopherol; α-TT, α-tocotrienol; SP, sphinganine; PC, PC (22 : 5 (7Z, 10Z, 13Z, 16Z, 19Z)/16 : 0); Cer, cer (d18 : 0/16 : 0); PS, phytosphingosine).